Moreover, PNPLA3 148M allele carriers with HCV infection have been reported to have increased prevalence of steatosis, fibrosis, cirrhosis and hepatocellular carcinoma [18-21]. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.